nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adoptive Immunotherapy with Cytokine-Induced Killer Cells for Patients with Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation
|
Laport, Ginna G. |
|
2011 |
17 |
11 |
p. 1679-1687 9 p. |
artikel |
2 |
A Multicenter Pilot Evaluation of the National Institutes of Health Chronic Graft-versus-Host Disease (cGVHD) Therapeutic Response Measures: Feasibility, Interrater Reliability, and Minimum Detectable Change
|
Mitchell, Sandra A. |
|
2011 |
17 |
11 |
p. 1619-1629 11 p. |
artikel |
3 |
Anti-HLA Antibodies in Double Umbilical Cord Blood Transplantation
|
Brunstein, Claudio G. |
|
2011 |
17 |
11 |
p. 1704-1708 5 p. |
artikel |
4 |
Changes of Hepatitis B Virus Serologic Status after Allogeneic Hematopoietic Stem Cell Transplantation and Impact of Donor Immunity on Hepatitis B Virus
|
Park, Silvia |
|
2011 |
17 |
11 |
p. 1630-1637 8 p. |
artikel |
5 |
CIK: A Path to GVL without GVHD?
|
Martin, Paul J. |
|
2011 |
17 |
11 |
p. 1571-1572 2 p. |
artikel |
6 |
Contribution of HLA-A/B/C/DRB1/DQB1 Common Haplotypes to Donor Search Outcome in Unrelated Hematopoietic Stem Cell Transplantation
|
Pédron, Béatrice |
|
2011 |
17 |
11 |
p. 1612-1618 7 p. |
artikel |
7 |
Decreased Serum Albumin as a Biomarker for Severe Acute Graft-versus-Host Disease after Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation
|
Rezvani, Andrew R. |
|
2011 |
17 |
11 |
p. 1594-1601 8 p. |
artikel |
8 |
Dynamics of Cytomegalovirus (CMV) Plasma DNAemia in Initial and Recurrent Episodes of Active CMV Infection in the Allogeneic Stem Cell Transplantation Setting: Implications for Designing Preemptive Antiviral Therapy Strategies
|
Muñoz-Cobo, Beatriz |
|
2011 |
17 |
11 |
p. 1602-1611 10 p. |
artikel |
9 |
Editorial Board
|
|
|
2011 |
17 |
11 |
p. A2- 1 p. |
artikel |
10 |
Evaluation and Management of BK Virus-Associated Nephropathy Following Allogeneic Hematopoietic Cell Transplantation
|
Raval, Mihir |
|
2011 |
17 |
11 |
p. 1589-1593 5 p. |
artikel |
11 |
Expression of Activating KIR2DS2 and KIR2DS4 Genes after Hematopoietic Cell Transplantation: Relevance to Cytomegalovirus Infection
|
Gallez-Hawkins, Ghislaine M. |
|
2011 |
17 |
11 |
p. 1662-1672 11 p. |
artikel |
12 |
Factors Influencing the Outcome of a Second Autologous Stem Cell Transplant (ASCT) in Relapsed Multiple Myeloma: A Study from the British Society of Blood and Marrow Transplantation Registry
|
Cook, Gordon |
|
2011 |
17 |
11 |
p. 1638-1645 8 p. |
artikel |
13 |
Fludarabine, Antithymocyte Globulin, and Very Low-Dose Busulfan for Reduced-Intensity Conditioning before Allogeneic Stem Cell Transplantation in Patients with Lymphoid Malignancies
|
Malard, Florent |
|
2011 |
17 |
11 |
p. 1698-1703 6 p. |
artikel |
14 |
Improved Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Recent Years. A Single-Center Study
|
Remberger, Mats |
|
2011 |
17 |
11 |
p. 1688-1697 10 p. |
artikel |
15 |
Incidence and Prognostic Value of Eosinophilia in Chronic Graft-versus-Host Disease after Nonmyeloablative Hematopoietic Cell Transplantation
|
Ahmad, Imran |
|
2011 |
17 |
11 |
p. 1673-1678 6 p. |
artikel |
16 |
Masthead
|
|
|
2011 |
17 |
11 |
p. A1- 1 p. |
artikel |
17 |
National Cancer Institute–National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on Late Effects After Pediatric Hematopoietic Cell Transplantation: Long-Term Organ Damage and Dysfunction
|
Nieder, Michael L. |
|
2011 |
17 |
11 |
p. 1573-1584 12 p. |
artikel |
18 |
Officers and Directors of ASBMT
|
|
|
2011 |
17 |
11 |
p. A3- 1 p. |
artikel |
19 |
“Pet Negativity”—The New Goal of Cytoreductive Therapy in Hodgkin's Lymphoma?
|
Sweetenham, John W. |
|
2011 |
17 |
11 |
p. 1569-1570 2 p. |
artikel |
20 |
Pretransplantation Liver Function Impacts on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: A Study of 455 Patients
|
Barba, Pere |
|
2011 |
17 |
11 |
p. 1653-1661 9 p. |
artikel |
21 |
Prognostic Significance of FDG-PET in Relapsed or Refractory Classical Hodgkin Lymphoma Treated with Standard Salvage Chemotherapy and Autologous Stem Cell Transplantation
|
Smeltzer, Jacob P. |
|
2011 |
17 |
11 |
p. 1646-1652 7 p. |
artikel |
22 |
Safety and Immunogenicity of the Live Attenuated Varicella Vaccine Following T Replete or T Cell-Depleted Related and Unrelated Allogeneic Hematopoietic Cell Transplantation (alloHCT)
|
Chou, Joanne F. |
|
2011 |
17 |
11 |
p. 1708-1713 6 p. |
artikel |
23 |
Table of Contents
|
|
|
2011 |
17 |
11 |
p. A5-A8 nvt p. |
artikel |
24 |
The Incidence of Veno-Occlusive Disease Following Allogeneic Hematopoietic Stem Cell Transplantation Has Diminished and the Outcome Improved over the Last Decade
|
Carreras, Enric |
|
2011 |
17 |
11 |
p. 1713-1720 8 p. |
artikel |
25 |
The Role of Anti-HLA Antibodies in Hematopoietic Stem Cell Transplantation
|
Focosi, Daniele |
|
2011 |
17 |
11 |
p. 1585-1588 4 p. |
artikel |